WearLinq Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $14M

  • Investors
  • 21

WearLinq General Information

Description

Developer of a health monitoring and diagnosis device designed to enhance patient care and clinical outcomes. The company's device records a multi-lead electrocardiogram and transmits it in real-time with AI to detect typical irregular heart rhythms, including a normal heart rhythm, bradycardia, and tachycardia, enabling users to discover history and trends, set reminders, and connect directly with physicians.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1819 Polk Street
  • Suite 148
  • San Francisco, CA 94109
  • United States
+1 (415)
Primary Industry
Monitoring Equipment
Other Industries
Application Software
Other Healthcare Technology Systems
Corporate Office
  • 1819 Polk Street
  • Suite 148
  • San Francisco, CA 94109
  • United States
+1 (415)

WearLinq Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

WearLinq Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A) 18-Dec-2025 $14M Completed Generating Revenue
5. Later Stage VC (Series A1) 29-Apr-2025 Completed Generating Revenue
4. Early Stage VC (Series A) 21-May-2024 Completed Product In Beta Test
3. Product Crowdfunding 11-Jul-2020 Completed Product In Beta Test
2. Seed Round 01-Jan-2020 $2.7M $2.7M Completed Startup
1. Accelerator/Incubator Completed Startup
To view WearLinq’s complete valuation and funding history, request access »

WearLinq Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2
Series A-1
Series A
Seed-3
Seed-2 604,612 $0.000100 $0.36 $0.36 1x $0.36 1.21%
Seed-1 3,585,229 $0.000100 $0.46 $0.46 1x $0.46 7.2%
To view WearLinq’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

WearLinq Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a health monitoring and diagnosis device designed to enhance patient care and clinical outcomes. The compan
Monitoring Equipment
San Francisco, CA
19 As of 2025

Golden, CO
 

San Jose, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

WearLinq Competitors (2)

One of WearLinq’s 2 competitors is BioIntelliSense, a Venture Capital-Backed company based in Golden, CO.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioIntelliSense Venture Capital-Backed Golden, CO
VitalConnect Formerly VC-backed San Jose, CA
You’re viewing 2 of 2 competitors. Get the full list »

WearLinq Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

WearLinq Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alumni Ventures Venture Capital Minority
AngelSchool.vc Angel Group Minority
Celtic House Asia Partners Venture Capital Minority
CHAP Health Ventures Venture Capital Minority
Device of Tomorrow Capital Venture Capital Minority
You’re viewing 5 of 21 investors. Get the full list »

WearLinq Acquisitions (1)

WearLinq’s most recent deal was a Merger/Acquisition with AMI Cardiac Monitoring. The deal was made on 21-May-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
AMI Cardiac Monitoring 21-May-2024 Merger/Acquisition Clinics/Outpatient Services
To view WearLinq’s complete acquisitions history, request access »

WearLinq Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
AMI Cardiac Monitoring Rockville, MD 1991

WearLinq FAQs

  • When was WearLinq founded?

    WearLinq was founded in 2020.

  • Where is WearLinq headquartered?

    WearLinq is headquartered in San Francisco, CA.

  • What is the size of WearLinq?

    WearLinq has 19 total employees.

  • What industry is WearLinq in?

    WearLinq’s primary industry is Monitoring Equipment.

  • Is WearLinq a private or public company?

    WearLinq is a Private company.

  • What is WearLinq’s current revenue?

    The current revenue for WearLinq is .

  • How much funding has WearLinq raised over time?

    WearLinq has raised $35M.

  • Who are WearLinq’s investors?

    Alumni Ventures, AngelSchool.vc, Celtic House Asia Partners, CHAP Health Ventures, and Device of Tomorrow Capital are 5 of 21 investors who have invested in WearLinq.

  • Who are WearLinq’s competitors?

    BioIntelliSense and VitalConnect are competitors of WearLinq.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process